NCT06139211 2024-12-20A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid TumorsShanghai Junshi Bioscience Co., Ltd.Phase 1/2 Recruiting186 enrolled
NCT03154294 2024-07-26Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid TumorsAvera McKennan Hospital & University Health CenterPhase 1 Completed19 enrolled 16 charts